Delivery Order SPE2DB22D2206-SPE2DB23FKF91
Award Date 9/11/23
Potential Completion Date 9/12/23
Potential Value $46K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $8,541.31 to Amerisourcebergen Drug Corporation for the provision of 4561966068 Pulmozyme 1 MG/ML ampules. Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical products to a location in Conshohocken, Pennsylvania by August 29, 2023 in fulfillment of this order issued under an existing DLA contract vehicle. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $30,000 to Amerisourcebergen Drug Corporation to supply Pulmozyme 1 mg/ml ampules. The delivery order was issued under an existing Amerisourcebergen contract vehicle and calls for the contractor to deliver 2.5ml ampules of the respiratory drug to a location in Conshohocken, Pennsylvania, with performance to be completed between September 8-11, 2023. Amerisourcebergen Corporation will perform as the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twelve thousand five hundred seventeen dollars and fifty-nine cents ($12,517.59) to Amerisourcebergen Drug Corporation for 4561315770 Pulmozyme 1 mg/ml ampul 2.5ml. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania by June 23, 2023. No additional details were provided regarding the original solicitation requirements. Amerisourcebergen Corporation is the parent company of...
- The Defense Logistics Agency awarded a $14,683.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561948828 Pulmozyme 1 mg/ml ampul 2.5ml. The contract has a period of performance from August 25, 2023 through August 28, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency leverages contracts such as Federal Supply Schedule 65IIa...
- The Defense Logistics Agency awarded a $6,394.32 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561851817 Pulmozyme 1 MG/ML ampules. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the medication to a location in Conshohocken, Pennsylvania by August 18, 2023 in fulfillment of this order issued under an indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $19,316 delivery order to Amerisourcebergen Drug Corporation for 4561806979 Pulmozyme 1 MG/ML Ampul 2.5ML. The firm fixed price order is for delivery of the specified pharmaceutical product to a location in Conshohocken, Pennsylvania, with performance required from August 14 to August 15, 2023. As a top supplier of medical materiel to the Department of Defense, Amerisourcebergen will fulfill this order from the Defense Logistics Agency in support of the...
- The Defense Logistics Agency awarded a delivery order valued at $18,547.65 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and fulfills this order through its corporate office location at the same address....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,356.71 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampule 2.5ml pharmaceutical supplies. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 18, 2025, issued on September 17, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $24,134.90 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampules (2.5 ml units) with a firm fixed price structure. This is a non-set-aside competitive award with a completion date of December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $8,205.90 to Amerisourcebergen Drug Corporation for the supply of 4562087031 Pulmozyme 1 mg/ml ampul 2.5ml. Amerisourcebergen Drug Corporation will perform as the prime contractor, with corporate oversight provided by its parent company, Amerisourcebergen Corporation. Performance will take place in Conshohocken, Pennsylvania over a two day period from September 7 through September 8, 2023. No subcontractors or set...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FKF91Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $46,185.49 to Amerisourcebergen Drug Corporation for 4562127047 Pulmozyme 1 MG/ML ampules. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 12, 2023 under the terms of the order. As a major provider of medical supplies and logistics support to the U.S. Department of Defense, this award for respiratory medications furthers the Defense Logistics Agency's mission to provide critical healthcare resources and sustainment items to military treatment facilities worldwide.
Generated 12/19/23, 7:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.2k | 9/11/23 |